ID

38756

Description

A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01680978

Lien

https://clinicaltrials.gov/show/NCT01680978

Mots-clés

Versions (1)
  1. 31/10/2019 31/10/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

31 octobre 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Diabetes Mellitus, Type 2 NCT01680978

Anglais

Eligibility Diabetes Mellitus, Type 2 NCT01680978

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, 40 to 70 years of age (inclusive) at screening
Description

Adult | Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
patients with type 2 diabetes mellitus diagnosed at least 12 weeks before screening and either drug-naïve or treated with stable metformin monotherapy for at least 12 weeks prior to screening
Description

Non-Insulin-Dependent Diabetes Mellitus Disease length | Pharmaceutical Preparations Absent | Metformin Stable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0025598
UMLS CUI [3,2]
C0205360
hba1c >/= 7 % and </= 9% at screening
Description

Hemoglobin A1c measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0474680
absence of history of coronary artery disease
Description

Coronary Artery Disease Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C1956346
UMLS CUI [1,2]
C0332197
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
diagnosis or history of type 1 diabetes mellitus, diabetes resulting from pancreatic injury, or secondary forms of diabetes
Description

Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus Due to Injury of pancreas | Secondary diabetes mellitus

Type de données

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2,1]
C0011849
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0273163
UMLS CUI [3]
C0271640
current treatment with fibrates, thiazolidinediones, or insulin
Description

Fibrates | Thiazolidinediones | Insulin

Type de données

boolean

Alias
UMLS CUI [1]
C1449704
UMLS CUI [2]
C1257987
UMLS CUI [3]
C0021641
prior intolerance to thiazolidinediones and/or fibrates
Description

Intolerance to Thiazolidinediones | Intolerance to Fibrates

Type de données

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C1257987
UMLS CUI [2,1]
C1744706
UMLS CUI [2,2]
C1449704
clinically significant liver disease or impaired liver function
Description

Liver disease | Liver Dysfunction

Type de données

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0086565
know chronic diabetic complications (i.e. retinopathy, neuropathy, nephropathy)
Description

Complications of Diabetes Mellitus chronic | Retinal Disease | Neuropathy | Kidney Disease

Type de données

boolean

Alias
UMLS CUI [1,1]
C0342257
UMLS CUI [1,2]
C0205191
UMLS CUI [2]
C0035309
UMLS CUI [3]
C0442874
UMLS CUI [4]
C0022658
symptomatic congestive heart failure classified as nyha class ii-iv
Description

Symptomatic congestive heart failure New York Heart Association Classification

Type de données

boolean

Alias
UMLS CUI [1,1]
C0742758
UMLS CUI [1,2]
C1275491
diagnosed and/or treated malignancy within the past 5 years, except for treated basal cell skin cancer, in situ carcinoma of the cervix, or in situ prostate cancer
Description

Malignant Neoplasms | Cancer treatment | Exception Basal cell carcinoma Treated | Exception Carcinoma in situ of uterine cervix Treated | Exception Carcinoma in situ of prostate Treated

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0920425
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0007117
UMLS CUI [3,3]
C1522326
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0851140
UMLS CUI [4,3]
C1522326
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0154088
UMLS CUI [5,3]
C1522326
contraindications to mri, or inability to tolerate mri scanning
Description

Medical contraindication MRI | MRI scan Receive Unable

Type de données

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0024485
UMLS CUI [2,1]
C0024485
UMLS CUI [2,2]
C1514756
UMLS CUI [2,3]
C1299582
Retour au début de la page

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT01680978

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adult patients, 40 to 70 years of age (inclusive) at screening
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Non-Insulin-Dependent Diabetes Mellitus Disease length | Pharmaceutical Preparations Absent | Metformin Stable
Item
patients with type 2 diabetes mellitus diagnosed at least 12 weeks before screening and either drug-naïve or treated with stable metformin monotherapy for at least 12 weeks prior to screening
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0025598 (UMLS CUI [3,1])
C0205360 (UMLS CUI [3,2])
Hemoglobin A1c measurement
Item
hba1c >/= 7 % and </= 9% at screening
boolean
C0474680 (UMLS CUI [1])
Coronary Artery Disease Absent
Item
absence of history of coronary artery disease
boolean
C1956346 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus Due to Injury of pancreas | Secondary diabetes mellitus
Item
diagnosis or history of type 1 diabetes mellitus, diabetes resulting from pancreatic injury, or secondary forms of diabetes
boolean
C0011854 (UMLS CUI [1])
C0011849 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0273163 (UMLS CUI [2,3])
C0271640 (UMLS CUI [3])
Fibrates | Thiazolidinediones | Insulin
Item
current treatment with fibrates, thiazolidinediones, or insulin
boolean
C1449704 (UMLS CUI [1])
C1257987 (UMLS CUI [2])
C0021641 (UMLS CUI [3])
Intolerance to Thiazolidinediones | Intolerance to Fibrates
Item
prior intolerance to thiazolidinediones and/or fibrates
boolean
C1744706 (UMLS CUI [1,1])
C1257987 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C1449704 (UMLS CUI [2,2])
Liver disease | Liver Dysfunction
Item
clinically significant liver disease or impaired liver function
boolean
C0023895 (UMLS CUI [1])
C0086565 (UMLS CUI [2])
Complications of Diabetes Mellitus chronic | Retinal Disease | Neuropathy | Kidney Disease
Item
know chronic diabetic complications (i.e. retinopathy, neuropathy, nephropathy)
boolean
C0342257 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0035309 (UMLS CUI [2])
C0442874 (UMLS CUI [3])
C0022658 (UMLS CUI [4])
Symptomatic congestive heart failure New York Heart Association Classification
Item
symptomatic congestive heart failure classified as nyha class ii-iv
boolean
C0742758 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Malignant Neoplasms | Cancer treatment | Exception Basal cell carcinoma Treated | Exception Carcinoma in situ of uterine cervix Treated | Exception Carcinoma in situ of prostate Treated
Item
diagnosed and/or treated malignancy within the past 5 years, except for treated basal cell skin cancer, in situ carcinoma of the cervix, or in situ prostate cancer
boolean
C0006826 (UMLS CUI [1])
C0920425 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0007117 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0851140 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
C1705847 (UMLS CUI [5,1])
C0154088 (UMLS CUI [5,2])
C1522326 (UMLS CUI [5,3])
Medical contraindication MRI | MRI scan Receive Unable
Item
contraindications to mri, or inability to tolerate mri scanning
boolean
C1301624 (UMLS CUI [1,1])
C0024485 (UMLS CUI [1,2])
C0024485 (UMLS CUI [2,1])
C1514756 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial